The relevant information included in this section is exactly as published on the website of the National Securities Market Commission (CNMV)

Filter results
Date Title Content PDF
28/07/2021 On business and financial situation ROVI releases the first half 2021 results presentation
28/07/2021 On business and financial situation The company releases the press release related to first half 2021 financial results
16/07/2021 On Corporate Governance ROVI announces the appointment of Juan López-Belmonte Encina as Chairman of the Company  
13/07/2021 Laboratorios Farmacéuticos Rovi regrets the passing of its President Juan López-Belmonte The Company informs about the passing of its President Juan López-Belmonte López
5/07/2021 Liquidity contracts and specialists Liquidity contract: transactions conducted in the second quarter of 2021
2/07/2021 Other relevant information The Company informs about the dividends payment 
22/06/2021 On significant placements in financial instruments Bestinver announces the beginning of an accelerated book build process of up to a 3% of the share capital of Laboratorios Rovi, S.A.
22/06/2021 On significant placements in financial instruments Hereby inform of the completion of the private placement package. The amount of the Placement amounted to a total of 87.88 million euros, being the unit selling price of 52.25 euros per share.
17/06/2021 Announcement of general shareholders’ meeting ROVI releases the information related to its General Shareholders Meeting
13/05/2021 Announcement of general shareholders’ meeting Rovi releases the information related to its 2021 General Shareholders Meeting

Pages